{"SPADE_UN_13988": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_13988", "Peptide Name": "C35", "Source": "Synthetic construct", "Family": "Retroviridae", "Gene": "Not found", "Sequence": "LSELDDRADALQAGASQFETSAAKLKRKYWWKN", "Sequence Length": 33, "UniProt Entry": "No entry found", "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Antiviral"], "Target Organism": "[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50>200 µM).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "[Ref.12054767]P4 cells:Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.", "Binding Target": "Integrase", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C169H262N48O52", "Mass": 3798.18, "PI": 8.38, "Net Charge": 1, "Hydrophobicity": -0.92, "Half Life": "Mammalian:5.5 hourYeast:3 minE.coli:2 min", "Mechanism of action": "Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.", "Literature": [{"Title": "A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.", "Pubmed ID": "12054767", "Reference": "J Mol Biol. 2002 Apr 19;318(1)45-58.", "Author": "de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=12054767"}], "Frequent Amino Acids": "AKL", "Absent Amino Acids": "CHIMOPUV", "Basic Residues": 6, "Acidic Residues": 5, "Hydrophobic Residues": 14, "Polar Residues": 20, "Positive Residues": 6, "Negative Residues": 5, "Similar Sequences": []}}}